Subtype
Bone Neoplasm
CI-CAN-00000569Explore in graph →
Non-malignant65 active trials4 approved drugs16 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000569Explore in graph →
Clinical trials
342 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03295981 | Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | recruiting | Phase 3 | 120 | St. Louis UniversityOTHER | 3 | Apr 22, 2026 | clinicaltrials |
| NCT02923011 | Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas | recruiting | Phase 3 | 56 | Matthew BucknorOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06669013 |
| Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas(FollowTheDIN) |
| recruiting |
| Phase 3 |
| 40 |
| N.N. Petrov National Medical Research Center of OncologyOTHER |
| 1 |
| Nov 1, 2024 |
| clinicaltrials |
Data updated 22 days agoSource updated Apr 22, 2026source: clinicaltrials